Universal Beteiligungs und Servicegesellschaft mbH Acquires 218,022 Shares of Oscar Health, Inc. $OSCR

Universal Beteiligungs und Servicegesellschaft mbH grew its holdings in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 1,097.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 237,882 shares of the company's stock after buying an additional 218,022 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH owned 0.09% of Oscar Health worth $3,418,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Farther Finance Advisors LLC boosted its holdings in shares of Oscar Health by 4,420.7% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,311 shares of the company's stock valued at $25,000 after buying an additional 1,282 shares in the last quarter. Strs Ohio bought a new stake in shares of Oscar Health during the 1st quarter valued at $30,000. Jones Financial Companies Lllp boosted its holdings in shares of Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock valued at $30,000 after buying an additional 2,242 shares in the last quarter. Quarry LP boosted its holdings in shares of Oscar Health by 439.8% during the 3rd quarter. Quarry LP now owns 1,803 shares of the company's stock valued at $34,000 after buying an additional 1,469 shares in the last quarter. Finally, Tsfg LLC bought a new stake in shares of Oscar Health during the 3rd quarter valued at $38,000. Institutional investors own 75.70% of the company's stock.

Insider Activity at Oscar Health

In other Oscar Health news, CEO Mark T. Bertolini purchased 1,000,000 shares of Oscar Health stock in a transaction dated Monday, April 6th. The stock was purchased at an average price of $11.92 per share, with a total value of $11,920,000.00. Following the transaction, the chief executive officer directly owned 10,196,876 shares of the company's stock, valued at $121,546,761.92. This trade represents a 10.87% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 24.39% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on OSCR. Weiss Ratings restated a "sell (d)" rating on shares of Oscar Health in a report on Tuesday, April 21st. Barclays set a $18.00 target price on shares of Oscar Health and gave the company an "equal weight" rating in a report on Monday, January 5th. Jefferies Financial Group upgraded shares of Oscar Health from an "underperform" rating to a "hold" rating and upped their price target for the stock from $10.00 to $16.00 in a research note on Monday, April 20th. UBS Group reiterated a "neutral" rating and issued a $15.00 price target on shares of Oscar Health in a research note on Wednesday, February 11th. Finally, Wall Street Zen upgraded shares of Oscar Health from a "sell" rating to a "hold" rating in a research note on Saturday, February 14th. Two investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company's stock. Based on data from MarketBeat, Oscar Health currently has a consensus rating of "Hold" and a consensus price target of $16.78.

Oscar Health Price Performance

NYSE OSCR opened at $17.89 on Thursday. Oscar Health, Inc. has a 52 week low of $10.69 and a 52 week high of $23.80. The firm has a market capitalization of $5.33 billion, a P/E ratio of -10.28 and a beta of 1.93. The company has a quick ratio of 0.96, a current ratio of 0.96 and a debt-to-equity ratio of 0.44. The company has a 50-day moving average price of $13.92 and a 200-day moving average price of $15.36.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Tuesday, February 10th. The company reported ($1.24) EPS for the quarter, missing the consensus estimate of ($0.92) by ($0.32). Oscar Health had a negative net margin of 3.79% and a negative return on equity of 39.35%. The business had revenue of $2.81 billion for the quarter, compared to analysts' expectations of $3.12 billion. During the same period in the previous year, the company earned ($0.62) EPS. Oscar Health's revenue for the quarter was up 17.3% compared to the same quarter last year. Equities research analysts anticipate that Oscar Health, Inc. will post 0.2 earnings per share for the current year.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.